Neuroendocrine Carcinoma of Pancreas, also known as poorly-differentiated neuroendocrine neoplasm of pancreas, is related to pancreatic endocrine carcinoma and neuroendocrine tumor of pancreas. The drugs Sunitinib and Temsirolimus have been mentioned in the context of this disorder. Affiliated tissues include pancreas and liver.